Loss of bax alters tumor spectrum and tumor numbers in ARF-deficient mice

Cancer Research

Volumn 62, Issue 7, 2002, Pages 2184-2191

  Eischen, Christine M ^a   Rehg, Jerold E ^a   Korsmeyer, Stanley J ^b   Cleveland, John L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN P19; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE DELETION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; LYMPHOMA; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0036531956     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
2. Mediation of c-Myc-induced apoptosis by p53
3. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21wafI/cip1
4. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
5. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
6. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
7. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
8. Nucleolar Arf sequesters Mdm 2 and activates p53
9. p14ARF links the tumour suppressors RB and p53
10. Lowe E1A signaling to p53 involves the p19(ARF) tumor suppressor
11. p53 mutations in human cancers
12. The p16INK4a/CDKN2A tumor suppressor and its relatives
13. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
14. ARF
15. Tumor spectrum in ARF-deficient mice
16. Tumor spectrum analysis in p53-mutant mice
17. BCL-2 gene family and the regulation of programmed cell death
18. BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
19. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies
20. Apoptosis triggered by Myc-induced suppression of Bcl-XL or Bcl-2 is bypassed during lymphomagenesis
21. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
22. Mutations of the bak gene in human gastric and colorectal cancers
23. Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
24. Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines
25. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability
26. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes
27. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)
28. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells
29. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
30. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues
31. Novel primitive lymphoid tumors induced in transgenic mice by cooperation between myc and bcl-2
32. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
33. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
34. Haploid loss of bax leads to accelerated mammary tumor development in C3(l)/SV40-TAg transgenic mice: Reduction in protective apoptotic response at the preneoplastic stage
35. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
36. Bax accelerates tumorigenesis in p53-deficient mice
37. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR
38. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses
39. The ARF/p53 pathway
40. p53-independent functions of the p19(ARF) tumor suppressor
41. Refinement and precision in the classification of murine lymphomas by genotyping with immunoglobulin and T cell receptor probes
42. Age-related changes in the morphology and immunophenotype of spontaneous lymphomas of SJL/N mice
43. Progenitor tumors from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival
44. Pathology of mice commonly used in genetic engineering (C57BL/6; 129; B6,129; and FVB/N)
45. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
46. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein
47. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment
48. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis
49. Methylation silencing and mutations of the 14ARF and p16INK4a genes in colon cancer
50. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
51. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemia
52. Genomic alteration of the p19ARF encoding exons in T-cell acute lymphocytic leukemia
53. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma
54. Differential effects of p19Arf and p16Ink4a loss on senescence of murine bone marrow-derived pre-B cells and macrophages
55. Bax is a transcriptional target and mediator of c-myc-induced apoptosis
56. Arm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system
57. Expression of Bcl-XL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage
58. p53 mutations are associated with histologic transformation of follicular lymphoma
59. Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma